Quest Diagnostics Incorporated [DGX] stock prices are up 0.49% to $132.69 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The DGX shares have gain 1.35% over the last week, with a monthly amount drifted -9.64%, and not seem to be holding up well over a long-time horizon.
25-cent Stock Takes $11T Commodities Sector Digital
One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.
All the details are in the FREE online report you can get here.
On 24, May 2023, Inclusion and Diversity Council Inspires New and Ongoing Initiatives. In a post published today on Yahoo Finance, Quest Diagnostics
From an analyst’s perspective:
The stock price of Quest Diagnostics Incorporated [DGX] has been fluctuating between $120.40 and $158.34 over the past year. Currently, Wall Street analysts expect the stock to reach $148.14 within the next 12 months. Quest Diagnostics Incorporated [NYSE: DGX] shares were valued at $132.69 at the most recent close of the market. An investor can expect a potential return of 11.64% based on the average DGX price forecast.
Analyzing the DGX fundamentals
The most recent quarter, Quest Diagnostics Incorporated [NYSE:DGX] reported sales of 2.33 billion, representing a drop of -10.70%. In this publicly-traded organization, revenue per employee is $201,694, while income per employee is $19,224. Gross Margin for this corporation currently stands at +33.87% with Operating Margin at +16.41%, Pretax Margin comes in at +12.50%, and Net Margin reading is +9.53%. To continue investigating profitability, this company’s Return on Assets is posted at 7.12, Equity is 15.27, Total Capital is 14.71, and Invested Capital is 8.84. Taking a look at the Principal structure of this organization reveals enduring liabilities to the total capital at 44.44 and enduring liabilities to the whole assets at 36.72.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 131.18 points at the first support level, and at 129.66 for the second support level. However, for the 1st resistance point, the stock is sitting at 133.85, and for the 2nd resistance point, it is at 135.00.
Quest Diagnostics Incorporated [DGX] reported earnings per share of $2.04 for its fiscal quarter that ended on 3/30/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of $1.97/share, meaning a difference of $0.07 and a surprise factor of 3.60%. By comparison, the stated earnings for the previous quarter ended on 12/30/2022 were $1.98 per share as compared to estimates of $1.91 per share, a difference of $0.07 representing a surprise of 3.70%.
Ratios To Look Out For
It’s worth pointing out that Quest Diagnostics Incorporated [NYSE:DGX]’s Current Ratio is 1.30. Also, the Quick Ratio is 1.10, while the Cash Ratio stands at 0.20. Considering the valuation of this stock, the price to sales ratio is 1.87, the price to book ratio is 2.95 and the P/E (TTM) ratio is 19.61.
Transactions by insiders
We now turn our attention to insider trading, which in the past 3 months has resulted in 7 insider buyings of 122,829 shares and 20 insider sellings of 74,518 shares. Recent insider trading involved Doherty Catherine T., SVP, Regional Businesses, that happened on Mar 07 when 5307.0 shares were sold. SVP & General Counsel, PREVOZNIK MICHAEL E completed a deal on Mar 07 to sell 4754.0 shares. Meanwhile, SVP, Regional Businesses Doherty Catherine T. sold 717.0 shares on Mar 03.